Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
Clinical trial NCT02710890 · COMPLETED
Trial details
- NCT number
- NCT02710890
- Sponsor
- UCB BIOSCIENCES, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-30
- Primary completion
- 2019-06-28
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.